Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
78.97%
0%
78.97%
6 Months
78.97%
0%
78.97%
1 Year
78.97%
0%
78.97%
2 Years
78.97%
0%
78.97%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Farmaceutica Remedia SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.75%
EBIT Growth (5y)
-15.65%
EBIT to Interest (avg)
16.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0
Tax Ratio
46.24%
Dividend Payout Ratio
54.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.77%
ROE (avg)
17.17%
Valuation key factors
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.92
EV to EBIT
1.37
EV to EBITDA
1.24
EV to Capital Employed
0.82
EV to Sales
0.03
PEG Ratio
0.02
Dividend Yield
5.62%
ROCE (Latest)
59.52%
ROE (Latest)
16.46%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ
Mar'25
Dec'24
Change(%)
Net Sales
189.00
202.30
-6.57%
Operating Profit (PBDIT) excl Other Income
5.00
6.90
-27.54%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
2.80
5.50
-49.09%
Operating Profit Margin (Excl OI)
23.30%
34.30%
-1.10%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2025 is -6.57% vs 7.55% in Dec 2024
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2025 is -49.09% vs 292.86% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
743.80
593.40
25.35%
Operating Profit (PBDIT) excl Other Income
15.40
12.40
24.19%
Interest
0.70
0.70
Exceptional Items
0.00
0.00
Consolidate Net Profit
7.00
7.20
-2.78%
Operating Profit Margin (Excl OI)
17.10%
12.40%
0.47%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 25.35% vs 10.73% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -2.78% vs 24.14% in Dec 2023






